Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Exome Sequencing (WES) of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data

NCT03210285 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03210285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03210285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Exome Sequencing (WES) of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
July 31, 2017
Completion date
July 1, 2018
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acoustic neuroma, neurofibromatosis type 2, vestibular schwannoma